Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vicarious Surgical ( (RBOT) ) has issued an announcement.
On April 8, 2026, Vicarious Surgical Inc. held a special meeting of stockholders at which shareholders representing about 60.68% of the company’s total voting power were present in person or by proxy, establishing a quorum. At the meeting, holders of Class A and higher-vote Class B shares, as of the March 16, 2026 record date, considered a single proposal.
Stockholders voted to approve an amendment to the company’s Certificate of Incorporation authorizing a reverse stock split of all outstanding Class A and Class B shares, at a ratio to be set by the board within a range of 1-for-2 to 1-for-30. The reverse split authorization, which received 11,810,046 votes in favor versus 49,675 against, gives the board flexibility to consolidate shares and potentially influence the company’s share price and capital markets profile.
The most recent analyst rating on (RBOT) stock is a Sell with a $0.73 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Neutral.
The score is driven primarily by very weak financial performance (no revenue, large losses, and heavy cash burn with shrinking equity) and bearish technicals (downtrend with negative momentum). Some offset comes from management’s cost-reduction actions and burn-reduction targets, but the OTC transition/delisting and ongoing funding/execution risks keep the overall score low.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc. is a medical technology company focused on developing and commercializing advanced robotic surgical systems. Operating in the surgical robotics industry, it targets hospitals and healthcare providers seeking minimally invasive solutions that combine robotics, computer science, and medical device innovation to improve surgical outcomes and operating room efficiency.
Average Trading Volume: 86,645
Technical Sentiment Signal: Sell
Current Market Cap: $5.41M
Find detailed analytics on RBOT stock on TipRanks’ Stock Analysis page.